Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Adamis Pharmaceuticals Q2 EPS $(3.40) Up From $(4.20) YoY, Sales $6.95K Down From $39.85K YoY

Author: Benzinga Newsdesk | August 21, 2023 09:19am
Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(3.40) per share. This is a 19.05 percent increase over losses of $(4.20) per share from the same period last year. The company reported $6.95 thousand in sales this quarter. This is a 82.57 percent decrease over sales of $39.85 thousand the same period last year.

Posted In: ADMP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist